On Tuesday Biogen's (NASDAQ: BIIB) Tecfidera/BG12 was approved by the FDA. In addition to approval, the drug's label is considered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE